Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Why Teva Pharmaceutical Stock Is Jumping Today | The Motley Fool
TEVA.N - | Stock Price & Latest News | Reuters
Teva announces debt recycling measures - Globes
Teva Pharmaceuticals Ireland today launches the first national respiratory inhaler recycling pilot
Why Teva Pharmaceutical Stock Is Sliding Today | The Motley Fool
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? | InvestorPlace
Teva Announces Launch of Generic Epiduo® in the United States | World Pharma Today
Teva Pharmaceutical Industries | Pharma 50
Teva to Launch New Growth Strategy at Investor Day
Teva Pharmaceuticals | The National Association of Free & Charitable Clinics
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Former Sandoz Chief Richard Francis joins Teva Pharma as President, CEO
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva, workers sign accord on Jerusalem factory closure terms | The Times of Israel
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
